Ask an Expert

Question of the Day

Bryan L. Roth, M.D., Ph.D.
September 16, 2011

I’m reminded on a daily basis how far we’ve come and yet how far we need to go to effectively treat schizophrenia and related disorders. I feel daily tremendous gratitude for the newer medications and have seen first-hand how miraculous the recoveries can be. On the other hand, I’m also a witness to the devastation effected by negative symptoms and cognitive deficits for which we have nothing, yet, of lasting benefit. I remain hopeful that technologies my lab and others have developed will point the way towards more comprehensive treatment strategies for schizophrenia and similar disorders.

Bryan L. Roth, M.D., Ph.D.
Scientific Council Member
Michael Hooker Distinguished Professor
Director, NIMH Psychoactive Drug Screening Program
University of North Carolina Chapel Hill Medical School

Rachel G. Klein, Ph.D., Scientific Council Member, 1995 NARSAD Distinguished Investigator Grantee, 2004 Ruane Prize for Outstanding Achievement in Child & Adolescent Psychiatric Research, Professsor of Psychiatry, New York University Child Study Center, Expert on Childhood mental illnesses including ADHD and anxiety
Q In your time on the Scientific Council, what is the most promising area of brain and behavior research you’ve seen?
A Two areas appear most promising. One is that great progress has been made... More >
Karl Deisseroth, M.D., Ph.D. - Brain and behavior research expert on schizophrenia
Q I know you treat people like my young adult son, who has schizophrenia. None of the experts we consulted asked about his childhood behavior patterns. Is it possible to intervene early to curb severe mental illness later in life?
A Indeed, we are now beginning to understand that people with... More >